Status:
UNKNOWN
Ductus Arteriosus Closure and D-Dimer and Fibrinogen Levels
Lead Sponsor:
Hacettepe University
Conditions:
Ductus Arteriosus, Patent
Eligibility:
All Genders
Up to 28 years
Brief Summary
The aim of this study is to investigate whether there is a relationship between echocardiographic measurements regarding closure of PDA and serum D-Dimer and Fibrinogen levels in premature infants bor...
Detailed Description
Ductus arteriosus (DA) is located between the main pulmonary artery and descending aorta in embryonal life, with dense spiral-located smooth muscle cells in the media layer, and the intima layer is th...
Eligibility Criteria
Inclusion
- premature newborns born before 32nd gestational week and weighing less than 1500 grams.
Exclusion
- Babies with:
- Major congenital anomalies
- Chromosomal anomalies
- Inborn errors of metabolism
- Hypoxic ischemic encephalopathy
- Disseminated intravascular coagulation
- Unstable hemodynamic status
- Severe neonatal sepsis
- Who died in time frame of postnatal 14 days
- Patients who are not volunteered to participate
Key Trial Info
Start Date :
March 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04508036
Start Date
March 14 2019
End Date
December 31 2023
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Turkey (Türkiye)